Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-27

Clinical Trial Update: High Fructose Corn Syrup [NA]

View source ↗

Summary

A completed clinical trial investigating the effects of high fructose corn syrup in relation to nonalcoholic fatty liver disease and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • High-fructose corn syrup

Snippet

Sponsor: Washington University School of Medicine | Conditions: Nonalcoholic Fatty Liver Disease, Obesity | NA | Status: COMPLETED